Mabylon AG raised CHF 30M in funding to advance its lead program MY006. The round saw significant investment from former Roche management and board members.
Amount Raised
CHF30 Million
Round Type
Venture
SchlierenBiotechnologyInvestors
Description
Mabylon AG, based in Schlieren, Switzerland, specializes in human-derived antibodies. The company raised CHF 30M to complete a Phase Ia/b trial for its tri-specific antibody MY006. Major backers included former management and board members from Roche. The funds will help generate safety and efficacy data by 2027.
Quick answer
Mabylon AG raised CHF30 Million in a funding round, dated August 12, 2025. Investors: Former Management And Board Members Of Roche. Mabylon AG is based in Schlieren, Zurich, Switzerland.
- How much did Mabylon AG raise?
- Mabylon AG raised CHF30 Million in a funding round on August 12, 2025.
- Who invested in Mabylon AG?
- Former Management And Board Members Of Roche is named as investors in this round.
- What does Mabylon AG do?
- Mabylon AG, a private Swiss biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders.
- Where is Mabylon AG based and how big is it?
- Mabylon AG is based in Schlieren, Zurich, Switzerland. Fundz records about 22 employees.
- Who are the decision-makers at Mabylon AG?
- Fundz holds 1 contact at Mabylon AG. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Mabylon AG that raised within 45 days of this round, from Fundz verified event records.
- Corner Therapeutics raised $17M on September 26, 2025.
- Simbryo Technologies raised $5.3M on September 26, 2025.
- Axon Therapeutics raised $32M (Series A) on September 26, 2025.
- Intactis Bio raised $100K (Pre-Seed) on September 26, 2025.
- enaDyne raised $8.2M (Seed) on September 25, 2025.
- Primum raised an undisclosed amount (Seed) on September 25, 2025.
Who to call at Mabylon AG, and when
A new round usually means Mabylon AG is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Mabylon AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mabylon AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mabylon AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mabylon AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Mabylon AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.